ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,684 | +4.2% | 16,090 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $316,529 | +12.1% | 15,930 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $282,474 | -12.5% | 16,490 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $322,709 | +12.8% | 16,490 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $286,000 | +16.3% | 17,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -11.2% | 17,900 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $277,000 | -27.5% | 17,490 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $382,000 | -26.4% | 17,490 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $519,000 | -32.5% | 17,364 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $769,000 | +15.5% | 17,364 | +15.6% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | -19.6% | 15,016 | -0.6% | 0.00% | -50.0% |
| Q4 2020 | $828,000 | +137.2% | 15,106 | -1.0% | 0.00% | +100.0% |
| Q3 2020 | $349,000 | +14.1% | 15,266 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $306,000 | – | 14,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |